Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections

Inclusion Criteria: * Patients with candidemia or with an invasive Candida infection * Presence of fever, hypothermia or other appropriate local sign of infection * Female patients must be non-lactating and at no risk of pregnancy Exclusion Criteria: * Patients with a sole diagnosis of mucocutaneous candidiasis, i.e. oropharyngeal, esophageal or genital candidiasis; or candidal lower urinary tract infection or Candida isolated solely from respiratory tract specimens * Patients with candidemia who failed a previous antifungal therapy for the same infection * Patients previously enrolled in a phase III study with isavuconazole * Patients with a body weight \<40kg